Immunovant (IMVT) Tax Rate (2018 - 2026)
Immunovant's (IMVT) quarterly Tax Rate came in at 1.9% in Q1 2026, up 245.0% YoY from 0.55% in Q1 2025, and up 233.34% on a QoQ basis from 1.42% in Q4 2025.
Powered by 
Analysis
Immunovant (IMVT) Tax Rate (2018 - 2026) Analysis & Trends
Immunovant (IMVT) has 9 years of Tax Rate data on file, last reported at 1.9% in Q1 2026.
- Quarterly Tax Rate rose 245.0% year-over-year to 1.9% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.04% (up 18.0% YoY) and the FY2026 annual result came in at 0.04%, up 18.0% from the prior year.
- Tax Rate advanced to 1.9% in Q1 2026, from 1.42% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 1.9% in Q1 2026 to a low of 1.42% in Q4 2025.
- A 5-year average of 0.17% and a median of 0.31% in 2024 frame the typical range for Tax Rate.
- Annual changes were most pronounced in 2024 — Tax Rate slumped 195 bps — and 2026, when it soared 245 bps.
- Tracing IMVT's Tax Rate over 5 years: stood at 0.62% in 2022, then jumped by 134 bps to 0.21% in 2023, then tumbled by 165 bps to 0.14% in 2024, then tumbled by 939 bps to 1.42% in 2025, then soared by 233 bps to 1.9% in 2026.
- The last three Tax Rate figures came in at 1.9% (Q1 2026), 1.42% (Q4 2025), and 0.47% (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -10.89% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 24.15% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 7.49% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -16.71% |
| 10 | Immunovant | 8.07 Bn | 8.07 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.89% |
| Dec 31, 2025 | -1.42% |
| Sep 30, 2025 | -0.47% |
| Jun 30, 2025 | -0.76% |
| Mar 31, 2025 | -0.55% |
| Dec 31, 2024 | -0.14% |
| Sep 30, 2024 | -0.07% |
| Jun 30, 2024 | -0.09% |
| Mar 31, 2024 | -0.31% |
| Dec 31, 2023 | 0.21% |
| Sep 30, 2023 | -0.78% |
| Jun 30, 2023 | 0.01% |
| Mar 31, 2023 | 1.64% |
| Dec 31, 2022 | -0.62% |
| Sep 30, 2022 | -0.55% |
| Jun 30, 2022 | -0.88% |
| Mar 31, 2022 | 0.03% |
| Sep 30, 2021 | 0.08% |
| Jun 30, 2021 | 0.13% |
| Mar 31, 2021 | 0.28% |